VivaVision Biotech has announced promising phase 2 clinical trial results for VVN461, a nonsteroidal...

The OneSight EssilorLuxottica Foundation has entered a strategic partnership with the World Health O...

Cambium Bio Limited, a clinical-stage regenerative medicine company, announced that it has successfu...

Galimedix Therapeutics Inc. has announced the initiation of dosing in a Phase 1 clinical trial for o...

Ocular Therapeutix has announced that over 300 patients have been randomized in the SOL-1 Phase 3 tr...

EyePoint Pharmaceuticals has successfully dosed the first patient in the LUCIA trial, marking the st...

Researchers at the University of Connecticut have uncovered promising findings that may pave the way...

PolyActiva has announced encouraging results from its Phase 2 clinical trial for the PA5108 glaucoma...

The Advanced Research Projects Agency for Health (ARPA-H) has announced funding of up to $125 millio...

Nicox has announced the completion of patient enrollment in China for the Denali Phase 3 trial, whic...